BG
CME icon

Bahl & Gaynor’s CME Group CME Stock Holding History

Bahl & Gaynor’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$186M Buy
630,722
+2,715
+0.4% +$806K 0.94% 32
2025
Q4 		$171M Buy
628,007
+31,104
+5% +$8.45M 0.87% 36
2025
Q3 		$161M Sell
596,903
-22,570
-4% -$6.14M 0.8% 39
2025
Q2 		$171M Sell
619,473
-11,067
-2% -$3.01M 0.86% 32
2025
Q1 		$167M Buy
630,540
+15,912
+3% +$3.93M 0.85% 35
2024
Q4 		$143M Buy
614,628
+57,439
+10% +$13.2M 0.75% 39
2024
Q3 		$123M Buy
557,189
+14,159
+3% +$2.93M 0.63% 46
2024
Q2 		$107M Buy
543,030
+46,714
+9% +$9.65M 0.6% 50
2024
Q1 		$107M Buy
496,316
+357,286
+257% +$75.1M 0.59% 51
2023
Q4 		$29.3M Buy
+139,030
New +$29.7M 0.18% 83
2020
Q3 		– Sell
-2,479
Closed -$403K – 333
2020
Q2 		$403K Sell
2,479
-3,845
-61% -$689K ﹤0.01% 295
2020
Q1 		$1.09M Sell
6,324
-25
-0.4% -$4.98K 0.01% 249
2019
Q4 		$1.27M Sell
6,349
-1,715
-21% -$352K 0.01% 265
2019
Q3 		$1.7M Buy
8,064
+161
+2% +$33.6K 0.01% 240
2019
Q2 		$1.53M Buy
+7,903
New +$1.46M 0.01% 249

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bahl & Gaynor's CME Position: Q1 2026 in Review

Bahl & Gaynor increased its CME Group (CME) stake by 0.43% in Q1 2026, buying an estimated $806K and bringing the position to 630,722 shares worth $186M. The position accounts for 0.94% of the portfolio, ranked #32.

Bahl & Gaynor first reported a position in CME in Q2 2019 and has held it in 15 quarters since. 1,793 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Bahl & Gaynor held 630,722 shares of CME Group worth $186M as of Q1 2026.
  • Bahl & Gaynor bought 2,715 CME Group shares in Q1 2026, an estimated $806K.
  • CME Group made up 0.94% of Bahl & Gaynor's portfolio in Q1 2026, its #32 holding.
  • Bahl & Gaynor first reported a position in CME Group in Q2 2019 and has held it in 15 quarters since.
  • 1,793 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Bahl & Gaynor's 13F filing for Q1 2026, filed 7 May 2026.